spacer
The Healthcare Sales & Marketing Network celebrates 26 years serving the medical sales & marketing community.Connecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product LinesConnecting Medical Independent Sales Reps and Distributors with Manufacturers and New Product Lines

Searching News Database:  alvimopan 

 HSMN NewsFeed - 1 Apr 2014
Cubist Appoints Robert J. Perez to Board of Directors
Biopharmaceuticals Personnel
 HSMN NewsFeed - 24 Oct 2013
Cubist Pharmaceuticals Completes Acquisition of Optimer Pharmaceuticals
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 21 Oct 2013
Cubist Announces FDA Approval for Expanded Use of ENTEREG(R)
Biopharmaceuticals Gastroenterology FDA
 HSMN NewsFeed - 24 Oct 2011
Cubist Pharmaceuticals to Acquire Adolor
Biopharmaceuticals Mergers & Acquisitions
 HSMN NewsFeed - 14 Jan 2010
Adolor Corporation Announces Management Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 7 Jan 2009
Adolor Corporation Announces Management Appointments
Biopharmaceuticals Personnel
 HSMN NewsFeed - 2 Sep 2008
Adolor Regains Rights to Entereg(R) (alvimopan) for OBD
Biopharmaceuticals
 HSMN NewsFeed - 3 Jul 2008
Adolor Provides Update on Entereg(R) (alvimopan) OBD Program
Biopharmaceuticals FDA
 HSMN NewsFeed - 2 Jun 2008
Adolor Promotes Dr. Lee Techner to Vice President, Medical Affairs and Medical Director
Biopharmaceuticals Personnel
 HSMN NewsFeed - 20 May 2008
Adolor and GlaxoSmithKline Announce FDA Approval of Entereg(R) (alvimopan) for the Management of Postoperative Ileus (POI)
Biopharmaceuticals FDA
 HSMN NewsFeed - 9 May 2008
Adolor Provides Regulatory Update on Entereg(R) (alvimopan)
Biopharmaceuticals
 HSMN NewsFeed - 8 Feb 2008
FDA Extends Review of NDA for ENTEREG(R) (alvimopan)
Biopharmaceuticals FDA
 HSMN NewsFeed - 23 Jan 2008
Adolor and GlaxoSmithKline Report Favorable FDA Advisory Committee Meeting for ENTEREG(R) (alvimopan) for the Management of Postoperative Ileus in Bowel Resection
Biopharmaceuticals
 HSMN NewsFeed - 28 Nov 2007
Adolor and GlaxoSmithKline Announce FDA Advisory Committee to Review Entereg(R) (alvimopan) for the Management of Postoperative Ileus (POI)
Biopharmaceuticals Surgery
 HSMN NewsFeed - 13 Sep 2007
FDA To Continue Its Review of Requests for Release of Clinical Hold on alvimopan (Entereg(R))
Biopharmaceuticals FDA
 HSMN NewsFeed - 28 Aug 2007
FDA Accepts for Review Complete Response to Approvable Letter for Entereg(R) (alvimopan) for POI
Biopharmaceuticals Surgery FDA
 HSMN NewsFeed - 11 Jun 2007
GSK and Adolor Update Alvimopan (Entereg/Entrareg(R)) Development Program
Biopharmaceuticals
 HSMN NewsFeed - 9 Apr 2007
GSK and Adolor Announce Preliminary Results from Phase 3 Safety Study of Alvimopan (ENTEREG/ENTRAREG(R))
Biopharmaceuticals
 HSMN NewsFeed - 14 Dec 2006
Adolor Elects Michael R. Dougherty Chief Executive Officer
Biopharmaceuticals Personnel
 HSMN NewsFeed - 14 Dec 2006
Adolor Announces Discontinuation of Sales Force and Other Selected Work Force Reductions
Biopharmaceuticals
 HSMN NewsFeed - 6 Nov 2006
FDA Issues Approvable Letter for Entereg(R) (alvimopan) for POI
Biopharmaceuticals FDA
 HSMN NewsFeed - 31 Oct 2006
Adolor Corporation Discontinues Development of Sterile Lidocaine Patch
Biopharmaceuticals Drug Delivery
 HSMN NewsFeed - 28 Jun 2006
Adolor Corporation Appoints Scott T. Megaffin as Vice President, Marketing
Biopharmaceuticals Personnel
 HSMN NewsFeed - 31 May 2006
Adolor's Complete Response to Approvable Letter for Entereg(R) (Alvimopan) in POI Accepted for Review by FDA
Biopharmaceuticals Gastroenterology Surgery FDA
 HSMN NewsFeed - 4 May 2006
GlaxoSmithKline and Adolor Present Positive Results from a Clinical Study of Alvimopan (Entereg(R))
Biopharmaceuticals
Return to NewsFeed  

 Additional items found! 32

Members: click here for search results from The HSMN Archive (password required)
Members Archive contains 32 additional stories matching:
alvimopan
(Password required)
FindReps - Find Great Medical Independent Sales Reps without recruiter fees.
FindReps - available on the Apple App Store for iPhone and iPad.